Últimas noticias sobre KWESST Micro Systems (NASDAQ:KWE) Bolsa

KWESST Micro Systems

KWESST Micro Systems Inc develops and commercializes next-generation tactical systems. The company offers breakthrough technology in lethal and non-lethal systems with broad application, including law enforcement and personal defence, modernized digitization of tactical forces for shared situational awareness and targeting, and counter-measures against threats such as drones, lasers and electronic detection.

Earnings

News

Markets

Trading Ideas

APDN

AUID

CERO

COMM

CRVS

EFSH

FSBW

NIVF

NUKK

PRTG

PRZO

PTPI

RZLV

SHLT

SSBK

TNXP

VSTE

Acciones de Corvus suben un 22,5% pre-market tras anunciar datos de Soquelitinib. Descubre más ganadores y perdedores.

Acciones de Corvus Pharmaceuticals (CRVS) suben alrededor del 22%; 20 acciones que se mueven en premercado

KWESST Micro Systems Inc. - common stock, no R/S concurrent with offering

KWESST Micro Systems Inc

KraneShares Trust KraneShares CSI China Internet ETF

Barclays analyst Michael Leithead maintains Dow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>) with a Equal-Weight and lowers the price target from $38 to $32.

Price Target

Analyst Ratings

Barclays Maintains Equal-Weight on Dow, Lowers Price Target to $32

AMETEK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) has outperformed the market over the past 15 years by 4.8% on an annualized basis producing an average annual return of 15.51%. Currently, AMETEK has a market capitalization of $38.59 billion. 
Buying $100 In AME: If an investor had bought $100 of AME stock 15 years ago, it would be worth $853.85 today based on a price of $167.24 for AME at the time of writing.
<h3>AMETEK's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745531128_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today

Barclays analyst Andrew Mok maintains UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) with a Overweight and lowers the price target from $560 to $513.

Barclays Maintains Overweight on UnitedHealth Group, Lowers Price Target to $513

Barclays analyst Matthew Bouley maintains Taylor Morrison Home (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMHC#NYSE">TMHC</a>) with a Overweight and lowers the price target from $70 to $69.

TMHC

Barclays Maintains Overweight on Taylor Morrison Home, Lowers Price Target to $69

Celestica Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) reported first-quarter financial results Thursday after the bell. Here&#8217;s a look at the key metrics <a href="https://www.benzinga.com/pressreleases/25/04/g44995314/celestica-announces-first-quarter-2025-financial-results">from the quarter</a>.
<ul>
<li>Q1 Revenue: $2.65 billion, versus <a href="https://www.benzinga.com/calendars/earnings">estimates</a> of $2.61 billion</li>
</ul>
<ul>
<li>Q1 Adjusted EPS: $1.20, versus estimates of $1.15</li>
</ul>
&#8220;Celestica delivered a strong&nbsp;first quarter&nbsp;in 2025, achieving revenue of&nbsp;$2.65 billion&nbsp;and non-GAAP adjusted EPS of&nbsp;$1.20, both surpassing the high end of our&nbsp;guidance&nbsp;ranges. This strong performance was further highlighted by our highest ever adjusted operating margin of&nbsp;7.1%,&#8221; said Rob Mionis, president and CEO of Celestica.
&#8220;With these results, and a strengthening demand&nbsp;outlook&nbsp;from our CCS customers, we are raising our full-year 2025&nbsp;outlook.&#8221;
See Also: <a href="https://www.benzinga.com/25/04/44995955/alphabet-q1-earnings-highlights-google-search-youtube-cloud-show-robust-momentum">Alphabet Q1 Earnings Highlights: Google Search, YouTube, Cloud Show &#8216;Robust Momentum&#8217;</a>
Outlook: Celestica guided for second-quarter revenue of $2.58 billion to $2.73 billion versus estimates of $2.77 billion. The company expects second-quarter adjusted earnings to be in the range of $1.17 to $1.27 per share versus <a href="http://pro.benzinga.com">Benzinga Pro</a> estimates of $1.24 per share. 
The company also raised its full-year 2025 outlook. Celestica raised its full-year revenue guidance from $10.7 billion to $10.85 billion, and raised its earnings outlook from $4.75 per share to $5 per share. The guidance is still below analyst estimates of $12.54 billion in revenue and earnings of $5.76 per share. 
The company noted that its guidance assumes no material changes to tariffs compared to what&#8217;s currently in effect, and no material changes from current macroeconomic trends and uncertainties. 
Celestica executives will further discuss the quarter on a call with investors and analysts Friday morning at 8 a.m. ET.
CLS Price Action: <a href="http://benzinga.com/quote/cls">Celstica shares</a> were down 3.25% after-hours, trading at $89.15 at the time of publication Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next: •<a href="https://www.benzinga.com/news/earnings/25/04/44997163/boston-beer-reports-strong-eps-beat-shipment-growth-in-q1"> Boston Beer Reports Strong EPS Beat, Shipment Growth In Q1</a>
Photo: Shutterstock.

Guidance

After-Hours Center

Movers

Celestica Beats Q1 Estimates, Raises FY Outlook On 'Strengthening Demand,' Shares Slide

Barclays analyst Brandon Oglenski maintains Southwest Airlines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>) with a Equal-Weight and lowers the price target from $32 to $26.

Barclays Maintains Equal-Weight on Southwest Airlines, Lowers Price Target to $26

Barclays analyst Raimo Lenschow maintains ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) with a Overweight and raises the price target from $967 to $969.

Barclays Maintains Overweight on ServiceNow, Raises Price Target to $969

<a href="https://www.bloomberg.com/news/articles/2025-04-24/hertz-eyes-500-million-debt-raise-ahead-of-litigation-payment">https://www.bloomberg.com/news/articles/2025-04-24/hertz-eyes-500-million-debt-raise-ahead-of-litigation-payment</a>

General

'Hertz Eyes $500 Million Debt Raise Ahead of Litigation Payment'- Bloomberg

Barclays analyst Manav Patnaik maintains Robert Half (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RHI#NYSE">RHI</a>) with a Equal-Weight and lowers the price target from $50 to $45.

Barclays Maintains Equal-Weight on Robert Half, Lowers Price Target to $45

Barclays analyst Jared Shaw maintains Popular (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPOP#NASDAQ">BPOP</a>) with a Overweight and raises the price target from $115 to $125.

BPOP

Barclays Maintains Overweight on Popular, Raises Price Target to $125

MarineMax, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HZO#NYSE">HZO</a>) soared on Thursday after the company <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b44974556/marinemax-reports-fiscal-2025-second-quarter-results" rel="noreferrer noopener">reported second-quarter results.</a>
The company reported adjusted earnings per share of 23 cents, beating the street view of 19 cents. Quarterly sales of $631.51 million (+8.3% year over year), outpacing the analyst consensus estimate of $578.77 million.
&#8220;Despite facing a weak retail market and an uncertain macroeconomic climate, we delivered a strong second-quarter performance,&#8221; said Brett McGill, Chief Executive Officer.
Also Read: <a target="_blank" href="https://www.benzinga.com/economics/macro-economic-events/25/04/44979310/durable-goods-orders-jump-9-2-in-march-but-one-category-tells-the-real-story" rel="noreferrer noopener">Durable Goods Orders Jump 9.2% In March, But One Category Tells The Real Story</a>
An increase in boat sales primarily drove the top-line growth. On a comparable same-store basis, revenue increased by 11%, reflecting additional contributions from products and services, including finance and insurance, the Superyachts Division, manufacturing and marinas.
Gross profit decreased 0.5% year over year to $189.5 million, while gross profit margin of 30.0% decreased 270 basis points.
This was primarily due to lower boat margins and the challenging retail environment. Adjusted EBITDA&nbsp;for the quarter increased to $30.9 million from $29.6 million for the comparable period last year.
&#8220;We ended the quarter with more than $200 million in cash and cash equivalents, and continue to reduce our long-term debt. Additionally, we have significant financing capacity through largely unused lines of credit,&#8221; McGill added.
Outlook: MarineMax expects fiscal year 2025 adjusted net income&nbsp;in the range of $1.40 to $2.40 per diluted share (estimate: $2.28), compared with a prior range of $1.80 to $2.80 per diluted share.
&#8220;The level of actual new sales seems to have slowed since the start of April. This suggests growing concern among consumers about the actual effects to the economy from the tariffs,&#8221; the CEO added.
Price Action: HZO shares closed higher by 17.30% to $22.67&nbsp;on Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44996394/chipotle-battles-slumping-sales-but-honey-chicken-boosts-hope-say-analysts" target="_blank" rel="noreferrer noopener">Chipotle Battles Slumping Sales, Analyst Pin Hope On Honey Chicken</a></li>
</ul>
Photo by Macklin Holloway via Shutterstock

Equities

Why Did MarineMax Stock Soar On Thursday

Barclays analyst Raimo Lenschow maintains Pegasystems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGA#NASDAQ">PEGA</a>) with a Equal-Weight and raises the price target from $84 to $96.

PEGA

Barclays Maintains Equal-Weight on Pegasystems, Raises Price Target to $96

Barclays analyst Brandon Oglenski maintains Old Dominion Freight Line (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODFL#NASDAQ">ODFL</a>) with a Equal-Weight and lowers the price target from $185 to $170.

ODFL

Barclays Maintains Equal-Weight on Old Dominion Freight Line, Lowers Price Target to $170

Barclays analyst Matthew Bouley maintains Masco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAS#NYSE">MAS</a>) with a Overweight and lowers the price target from $75 to $71.

Barclays Maintains Overweight on Masco, Lowers Price Target to $71

Barclays analyst Julian Mitchell maintains Lennox Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LII#NYSE">LII</a>) with a Overweight and lowers the price target from $702 to $696.

Barclays Maintains Overweight on Lennox Intl, Lowers Price Target to $696

Barclays analyst Brandt Montour maintains Las Vegas Sands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVS#NYSE">LVS</a>) with a Overweight and lowers the price target from $53 to $51.

Barclays Maintains Overweight on Las Vegas Sands, Lowers Price Target to $51

Barclays analyst Brandon Oglenski maintains Knight-Swift (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNX#NYSE">KNX</a>) with a Overweight and lowers the price target from $62 to $58.

Barclays Maintains Overweight on Knight-Swift, Lowers Price Target to $58

Bel Fuse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BELFA#NASDAQ">BELFA</a>) sees Q2 sales of $145.000 million-$155.000 million vs $158.75 million analyst estimate.

BELFA

Bel Fuse Sees Q2 Sales $145.000M-$155.000M vs $158.75M Est

Bel Fuse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BELFB#NASDAQ">BELFB</a>) reported quarterly earnings of $1.35 per share which beat the analyst consensus estimate of $0.94 by 43.62 percent. This is a 7.14 percent increase over earnings of $1.26 per share from the same period last year. The company reported quarterly sales of $152.24 million which beat the analyst consensus estimate of $130.25 million by 16.88 percent. This is a 18.85 percent increase over sales of $128.09 million the same period last year.

Earnings Beats

BELFB

Bel Fuse Q1 Adj. EPS $1.35 Beats $0.94 Estimate, Sales $152.24M Beat $130.25M Estimate

Barclays analyst Lauren Lieberman maintains Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Equal-Weight and lowers the price target from $139 to $135.

Comments

KWESST Micro Systems

Noticias

Últimas noticias sobre KWESST Micro Systems (NASDAQ:KWE) Bolsa

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL